| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Additional conditions recognized in this trial | ||||
| Diabetes Mellitus | |||||
| Diabetes Mellitus, Type 1 | |||||
| 2 | More general conditions related to this trial | ||||
| Autoimmune Diseases | |||||
| Endocrine System Diseases | |||||
| Glucose Metabolism Disorders | |||||
| Immune System Diseases | |||||
| Metabolic Diseases | |||||
| 3 | Interventions listed in this trial | ||||
| Islet cells infusion | |||||
| Sirolimus | |||||
| Tacrolimus | |||||
| Daclizumab | |||||
| Sulfamethoxazole | |||||
| Ganciclovir | |||||
| Trimethoprim | |||||
| Pentamidine | |||||
| 4 | More general drug interventions related to this trial | ||||
| Anti-Infective Agents | |||||
| Anti-Infective Agents, Urinary | |||||
| Antifungal Agents | |||||
| Antimalarials | |||||
| Antiparasitic Agents | |||||
| Antiprotozoal Agents | |||||
| Antiviral Agents | |||||
| Enzyme Inhibitors | |||||
| Folic Acid Antagonists | |||||
| Immunologic Factors | |||||
| Immunosuppressive Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Renal Agents | |||||
| Therapeutic Uses | |||||
| Trypanocidal Agents | |||||
| 5 | Sponsors listed in this trial | ||||
| National Institute of Allergy and Infectious Diseases (NIAID) | |||||
|
